Pharmatoka

Pharmatoka is a French pharmaceutical company specializing in the development and commercialization of evidence-based solutions for urinary health. The company is best known for its flagship product, Urell (marketed as Ellura in some regions), a highly concentrated cranberry extract standardized to provide a high dose of Type-A proanthocyanidins (PACs). Pharmatoka's business model focuses on providing non-antibiotic prophylactic options for recurrent urinary tract infections (UTIs) by utilizing a specific extraction process that inhibits the adhesion of P-fimbriated E. coli to the urinary tract wall. Headquartered in Rueil-Malmaison, the company maintains a strong presence in the international urology market through clinical validation and specialized manufacturing standards.